Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | ABCC6 CL E G H | 368 | 57 | OMIM:264800 | PSEUDOXANTHOMA ELASTICUM; PXE | | | | 415 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | ACP5 CL E G H | 54 | 124 | OMIM:607944 | Spondyloenchondrodysplasia with immune dysregulation | | | | 16 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | ACTA1 CL E G H | 58 | 129 | ORPHA:171439 | Childhood-onset nemaline myopathy | | | | 96 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | ACTA1 CL E G H | 58 | 129 | OMIM:255310 | Myopathy, congenital, with fiber-type disproportion | | | | 96 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | ACTA1 CL E G H | 58 | 129 | ORPHA:97244 | Rigid spine syndrome | HP:0040282 - Frequent | | | 96 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | ACTN2 CL E G H | 88 | 164 | OMIM:618654 | MYOPATHY, CONGENITAL, WITH STRUCTURED CORES AND Z-LINE ABNORMALITIES; MYOCOZ | | | | 307 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | AGRN CL E G H | 375790 | 329 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | | | | 127 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | AK9 CL E G H | 221264 | 33814 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | | | | 1 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | AKT1 CL E G H | 207 | 391 | ORPHA:2495 | Meningioma | HP:0040284 - Very rare | | | 54 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | ALMS1 CL E G H | 7840 | 428 | ORPHA:64 | Alström syndrome | | | | 404 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | ARSB CL E G H | 411 | 714 | OMIM:253200 | Mucopolysaccharidosis, type VI | | | | 120 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | B3GALT6 CL E G H | 126792 | 17978 | ORPHA:536467 | B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome | | | | 38 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | BAG3 CL E G H | 9531 | 939 | OMIM:612954 | Myopathy, myofibrillar, 6 | | | | 204 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | BAP1 CL E G H | 8314 | 950 | ORPHA:2495 | Meningioma | HP:0040284 - Very rare | | | 184 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | BICD2 CL E G H | 23299 | 17208 | OMIM:615290 | Spinal muscular atrophy, lower extremity-predominant, 2, autosomaldominant | | | | 46 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | BTNL2 CL E G H | 56244 | 1142 | OMIM:612387 | Sarcoidosis, susceptibility to, 2 | | | | 1 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | CD19 CL E G H | 930 | 1633 | ORPHA:1572 | Common variable immunodeficiency | | | | 38 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | CD81 CL E G H | 975 | 1701 | ORPHA:1572 | Common variable immunodeficiency | | | | 1 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | CEACAM3 CL E G H | 1084 | 1815 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | CEACAM6 CL E G H | 4680 | 1818 | ORPHA:586 | Cystic fibrosis | | | | 1 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | CFAP410 CL E G H | 755 | 1260 | OMIM:602271 | Spondylometaphyseal dysplasia, axial | | | | | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | CFTR CL E G H | 1080 | 1884 | OMIM:219700 | Cystic fibrosis | | | | 1371 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | CFTR CL E G H | 1080 | 1884 | ORPHA:586 | Cystic fibrosis | | | | 1371 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | CFTR CL E G H | 1080 | 1884 | ORPHA:60033 | Idiopathic bronchiectasis | | | | 1371 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | CHCHD10 CL E G H | 400916 | 15559 | ORPHA:457050 | Autosomal dominant mitochondrial myopathy with exercise intolerance | | | | 11 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | CHRNA1 CL E G H | 1134 | 1955 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | | | | 74 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | CHRNB1 CL E G H | 1140 | 1961 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | | | | 53 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | CHRND CL E G H | 1144 | 1965 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | | | | 88 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | CHRNE CL E G H | 1145 | 1966 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | | | | 139 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | CLCA4 CL E G H | 22802 | 2018 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | COL13A1 CL E G H | 1305 | 2190 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | | | | 6 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | COL2A1 CL E G H | 1280 | 2200 | OMIM:183900 | Spondyloepiphyseal dysplasia congenita | | | | 284 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | COL6A2 CL E G H | 1292 | 2212 | OMIM:255600 | Myosclerosis, autosomal recessive | | | | 478 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | COPA CL E G H | 1314 | 2230 | OMIM:616414 | AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE; AILJK | | | | 5 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | CR2 CL E G H | 1380 | 2336 | ORPHA:1572 | Common variable immunodeficiency | | | | 10 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | CRPPA CL E G H | 729920 | 37276 | ORPHA:352479 | ISPD-related limb-girdle muscular dystrophy R20 | | | | | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | CRPPA CL E G H | 729920 | 37276 | OMIM:616052 | Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7 | | | | | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | CSF2RA CL E G H | 1438 | 2435 | ORPHA:264675 | Hereditary pulmonary alveolar proteinosis | | | | 15 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | CSF2RA CL E G H | 1438 | 2435 | OMIM:300770 | SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 4; SMDP4 | | | | 15 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | CSF2RB CL E G H | 1439 | 2436 | ORPHA:264675 | Hereditary pulmonary alveolar proteinosis | | | | 17 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | CTLA4 CL E G H | 1493 | 2505 | ORPHA:900 | Granulomatosis with polyangiitis | | | | 10 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | DCTN4 CL E G H | 51164 | 15518 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | DDR2 CL E G H | 4921 | 2731 | OMIM:271665 | Spondylometaepiphyseal dysplasia, short Limb-Hand type | | | | 45 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | DKC1 CL E G H | 1736 | 2890 | OMIM:305000 | Dyskeratosis congenita, X-linked | | | | 65 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | DLK1 CL E G H | 8788 | 2907 | ORPHA:96334 | Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14 | | | | 1 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | DMD CL E G H | 1756 | 2928 | OMIM:310200 | Duchenne muscular dystrophy | | | | 1496 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | DNAH11 CL E G H | 8701 | 2942 | OMIM:611884 | CILIARY DYSKINESIA, PRIMARY, 7; CILD7 | | | | 542 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | DNAH9 CL E G H | 1770 | 2953 | OMIM:618300 | Ciliary dyskinesia, primary, 40 | | | | 18 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | DNASE1L3 CL E G H | 1776 | 2959 | ORPHA:36412 | Hypocomplementemic urticarial vasculitis | | | | 3 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | DOK7 CL E G H | 285489 | 26594 | OMIM:254300 | Myasthenia, limb-girdle, familial | | | | 91 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | DOK7 CL E G H | 285489 | 26594 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | | | | 91 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | EDNRA CL E G H | 1909 | 3179 | ORPHA:586 | Cystic fibrosis | | | | 3 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | EIF2AK4 CL E G H | 440275 | 19687 | ORPHA:199241 | Pulmonary capillary hemangiomatosis | | | | 40 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | EIF2AK4 CL E G H | 440275 | 19687 | OMIM:234810 | PULMONARY VENOOCCLUSIVE DISEASE 2, AUTOSOMAL RECESSIVE; PVOD2 | | | | 40 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | ENG CL E G H | 2022 | 3349 | OMIM:187300 | Telangiectasia, hereditary hemorrhagic, type 1 | | | | 186 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | FARSA CL E G H | 2193 | 3592 | OMIM:619013 | RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS 2; RILDBC2 | | | | | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | FCGR2A CL E G H | 2212 | 3616 | OMIM:219700 | Cystic fibrosis | | | | 6 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | FGFR3 CL E G H | 2261 | 3690 | ORPHA:15 | Achondroplasia | | | | 145 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | FKRP CL E G H | 79147 | 17997 | OMIM:606612 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5 | | | | 157 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | FKRP CL E G H | 79147 | 17997 | OMIM:607155 | Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5 | | | | 157 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | FLNB CL E G H | 2317 | 3755 | OMIM:272460 | Spondylocarpotarsal synostosis syndrome | | | | 233 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | FRG1 CL E G H | 2483 | 3954 | OMIM:158900 | Facioscapulohumeral muscular dystrophy 1 | | | | 1 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | GALNS CL E G H | 2588 | 4122 | OMIM:253000 | Morquio syndrome A | | | | 123 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | GCLC CL E G H | 2729 | 4311 | ORPHA:586 | Cystic fibrosis | | | | 2 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | GDAP1 CL E G H | 54332 | 15968 | ORPHA:99948 | Charcot-Marie-Tooth disease type 4A | | | | 108 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | GGPS1 CL E G H | 9453 | 4249 | OMIM:619518 | MUSCULAR DYSTROPHY, CONGENITAL HEARING LOSS, AND OVARIAN INSUFFICIENCY SYNDROME; MDHLO | | | | | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | GIPC1 CL E G H | 10755 | 1226 | ORPHA:98897 | Oculopharyngodistal myopathy | | | | | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | GLB1 CL E G H | 2720 | 4298 | OMIM:253010 | Mucopolysaccharidosis type IVB (Morquio) | | | | 120 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | GNPTAB CL E G H | 79158 | 29670 | ORPHA:576 | Mucolipidosis type II | | | | 240 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | GSTM3 CL E G H | 2947 | 4635 | ORPHA:586 | Cystic fibrosis | | | | 1 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | GZF1 CL E G H | 64412 | 15808 | OMIM:617662 | Joint laxity, short stature, and myopia | | | | | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | HES7 CL E G H | 84667 | 15977 | OMIM:613686 | Spondylocostal dysostosis 4, autosomal recessive | | | | 10 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | HFE CL E G H | 3077 | 4886 | ORPHA:586 | Cystic fibrosis | | | | 38 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | HLA-B CL E G H | 3106 | 4932 | ORPHA:36426 | Stevens-Johnson syndrome | | | | 4 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | HLA-DPA1 CL E G H | 3113 | 4938 | ORPHA:900 | Granulomatosis with polyangiitis | | | | | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | HLA-DPB1 CL E G H | 3115 | 4940 | ORPHA:133 | Chronic beryllium disease | HP:0040282 - Frequent | | | 1 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | HLA-DPB1 CL E G H | 3115 | 4940 | ORPHA:900 | Granulomatosis with polyangiitis | | | | 1 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:747 | Autoimmune pulmonary alveolar proteinosis | | | | 2 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | HLA-DRB1 CL E G H | 3123 | 4948 | OMIM:181000 | Sarcoidosis, susceptibility to, 1 | | | | 2 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | HMOX1 CL E G H | 3162 | 5013 | ORPHA:586 | Cystic fibrosis | | | | 3 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | HPS1 CL E G H | 3257 | 5163 | OMIM:203300 | Hermansky-Pudlak syndrome 1 | | | | 121 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | HPS4 CL E G H | 89781 | 15844 | OMIM:614073 | Hermansky-Pudlak syndrome 4 | | | | 123 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | ICOS CL E G H | 29851 | 5351 | ORPHA:1572 | Common variable immunodeficiency | | | | 32 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | IDS CL E G H | 3423 | 5389 | ORPHA:217093 | Mucopolysaccharidosis type 2, attenuated form | | | | 86 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | IDS CL E G H | 3423 | 5389 | ORPHA:217085 | Mucopolysaccharidosis type 2, severe form | | | | 86 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | IKZF1 CL E G H | 10320 | 13176 | ORPHA:36426 | Stevens-Johnson syndrome | | | | 8 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | IRF2BP2 CL E G H | 359948 | 21729 | ORPHA:1572 | Common variable immunodeficiency | | | | 4 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | ITCH CL E G H | 83737 | 13890 | OMIM:613385 | AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD | | | | 3 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | JAG2 CL E G H | 3714 | 6189 | OMIM:619566 | MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 27; LGMDR27 | | | | 1 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | KBTBD13 CL E G H | 390594 | 37227 | ORPHA:171439 | Childhood-onset nemaline myopathy | | | | 80 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | KCNN4 CL E G H | 3783 | 6293 | ORPHA:586 | Cystic fibrosis | | | | 3 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | KLHL41 CL E G H | 10324 | 16905 | ORPHA:171439 | Childhood-onset nemaline myopathy | | | | 13 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | LRP12 CL E G H | 29967 | 31708 | OMIM:164310 | Oculopharyngodistal myopathy 1 | | | | | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | LRP4 CL E G H | 4038 | 6696 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | | | | 124 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | MAP3K20 CL E G H | 51776 | 17797 | OMIM:617760 | Myopathy, centronuclear, 6, with fiber-type disproportion | | | | 2 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | MCIDAS CL E G H | 345643 | 40050 | OMIM:618695 | CILIARY DYSKINESIA, PRIMARY, 42; CILD42 | | | | 13 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | MEG3 CL E G H | 55384 | 14575 | ORPHA:96334 | Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14 | | | | 1 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | MEGF10 CL E G H | 84466 | 29634 | OMIM:614399 | Myopathy, areflexia, respiratory distress, and dysphagia, early-onset | | | | 158 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | MESP2 CL E G H | 145873 | 29659 | OMIM:608681 | Spondylocostal dysostosis 2, autosomal recessive | | | | 45 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | MIF CL E G H | 4282 | 7097 | ORPHA:586 | Cystic fibrosis | | | | 1 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | MS4A1 CL E G H | 931 | 7315 | ORPHA:1572 | Common variable immunodeficiency | | | | 1 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | MUC5B CL E G H | 727897 | 7516 | OMIM:178500 | Pulmonary fibrosis, idiopathic | | | | 133 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | MUSK CL E G H | 4593 | 7525 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | | | | 72 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | MYH7 CL E G H | 4625 | 7577 | ORPHA:324604 | Classic multiminicore myopathy | | | | 1269 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | MYH7 CL E G H | 4625 | 7577 | OMIM:255310 | Myopathy, congenital, with fiber-type disproportion | | | | 1269 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | MYH7 CL E G H | 4625 | 7577 | OMIM:608358 | Myopathy, myosin storage | | | | 1269 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | MYH7 CL E G H | 4625 | 7577 | OMIM:255160 | Myopathy, myosin storage, autosomal recessive | | | | 1269 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | MYO1H CL E G H | 283446 | 13879 | OMIM:619482 | CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL, 2, AND AUTONOMIC DYSFUNCTION; CCHS2 | | | | | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | MYOT CL E G H | 9499 | 12399 | ORPHA:266 | Autosomal dominant limb-girdle muscular dystrophy type 1A | | | | 75 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | MYPN CL E G H | 84665 | 23246 | ORPHA:171439 | Childhood-onset nemaline myopathy | | | | 217 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | MYPN CL E G H | 84665 | 23246 | OMIM:617336 | Nemaline myopathy 11, autosomal recessive | | | | 217 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | NAA10 CL E G H | 8260 | 18704 | OMIM:300855 | Ogden syndrome | | | | 23 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | NDUFAF6 CL E G H | 137682 | 28625 | OMIM:618913 | FANCONI RENOTUBULAR SYNDROME 5; FRTS5 | | | | 39 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | NEB CL E G H | 4703 | 7720 | ORPHA:171439 | Childhood-onset nemaline myopathy | | | | 745 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | NEK10 CL E G H | 152110 | 18592 | OMIM:618781 | CILIARY DYSKINESIA, PRIMARY, 44; CILD44 | | | | | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | NF2 CL E G H | 4771 | 7773 | ORPHA:2495 | Meningioma | HP:0040284 - Very rare | | | 220 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | NFKB1 CL E G H | 4790 | 7794 | ORPHA:1572 | Common variable immunodeficiency | | | | 7 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | NFKB2 CL E G H | 4791 | 7795 | ORPHA:1572 | Common variable immunodeficiency | | | | 11 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | NKX2-1 CL E G H | 7080 | 11825 | OMIM:610978 | Choreoathetosis, hypothyroidism, and neonatal respiratory distress | | | | 51 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | NLRP3 CL E G H | 114548 | 16400 | ORPHA:575 | Muckle-Wells syndrome | | | | 217 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | NOTCH2NLC CL E G H | 100996717 | 53924 | ORPHA:98897 | Oculopharyngodistal myopathy | | | | | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | PARN CL E G H | 5073 | 8609 | OMIM:616371 | PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 4; PFBMFT4 | | | | 26 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | PDGFB CL E G H | 5155 | 8800 | ORPHA:2495 | Meningioma | HP:0040284 - Very rare | | | 9 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | PIEZO2 CL E G H | 63895 | 26270 | OMIM:108145 | Arthrogryposis, distal, type 5 | | | | 77 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | PIK3CA CL E G H | 5290 | 8975 | ORPHA:2495 | Meningioma | HP:0040284 - Very rare | | | 162 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | PLOD1 CL E G H | 5351 | 9081 | ORPHA:1900 | Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency | | | | 105 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | PRKCD CL E G H | 5580 | 9399 | ORPHA:1572 | Common variable immunodeficiency | | | | 10 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | PRTN3 CL E G H | 5657 | 9495 | ORPHA:900 | Granulomatosis with polyangiitis | | | | | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | PTPN22 CL E G H | 26191 | 9652 | ORPHA:900 | Granulomatosis with polyangiitis | | | | 3 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | PYROXD1 CL E G H | 79912 | 26162 | OMIM:617258 | MYOPATHY, MYOFIBRILLAR, 8; MFM8 | | | | 5 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | RAPSN CL E G H | 5913 | 9863 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | | | | 73 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | RNF168 CL E G H | 165918 | 26661 | ORPHA:420741 | RIDDLE syndrome | | | | 7 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | RNU4ATAC CL E G H | 100151683 | 34016 | OMIM:226960 | EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS | | | | 15 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | RPA1 CL E G H | 6117 | 10289 | OMIM:619767 | PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 6; PFBMFT6 | | | | | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | RTEL1 CL E G H | 51750 | 15888 | OMIM:616373 | PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 3; PFBMFT3 | | | | 77 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | RTL1 CL E G H | 388015 | 14665 | ORPHA:96334 | Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14 | | | | | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | RYR1 CL E G H | 6261 | 10483 | OMIM:255310 | Myopathy, congenital, with fiber-type disproportion | | | | 1200 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SBF2 CL E G H | 81846 | 2135 | ORPHA:99956 | Charcot-Marie-Tooth disease type 4B2 | | | | 180 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SCN4A CL E G H | 6329 | 10591 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | | | | 263 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SCNN1A CL E G H | 6337 | 10599 | ORPHA:60033 | Idiopathic bronchiectasis | | | | 67 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SCNN1B CL E G H | 6338 | 10600 | ORPHA:60033 | Idiopathic bronchiectasis | | | | 61 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SCNN1G CL E G H | 6340 | 10602 | ORPHA:60033 | Idiopathic bronchiectasis | | | | 57 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SELENON CL E G H | 57190 | 15999 | ORPHA:324604 | Classic multiminicore myopathy | | | | 144 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SELENON CL E G H | 57190 | 15999 | OMIM:255310 | Myopathy, congenital, with fiber-type disproportion | | | | 144 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SELENON CL E G H | 57190 | 15999 | OMIM:602771 | Rigid spine muscular dystrophy 1 | | | | 144 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SELENON CL E G H | 57190 | 15999 | ORPHA:97244 | Rigid spine syndrome | HP:0040282 - Frequent | | | 144 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SERPINA1 CL E G H | 5265 | 8941 | ORPHA:586 | Cystic fibrosis | | | | 131 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SFTPA1 CL E G H | 653509 | 10798 | OMIM:619611 | INTERSTITIAL LUNG DISEASE 1; ILD1 | | | | 19 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SFTPA2 CL E G H | 729238 | 10799 | OMIM:178500 | Pulmonary fibrosis, idiopathic | | | | 10 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SFTPC CL E G H | 6440 | 10802 | OMIM:178500 | Pulmonary fibrosis, idiopathic | | | | 33 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SFTPC CL E G H | 6440 | 10802 | OMIM:610913 | Surfactant metabolism dysfunction, pulmonary, 2 | | | | 33 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SGCG CL E G H | 6445 | 10809 | OMIM:253700 | Muscular dystrophy, limb-girdle, type 2C | | | | 83 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SLC11A1 CL E G H | 6556 | 10907 | ORPHA:586 | Cystic fibrosis | | | | 2 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SLC12A6 CL E G H | 9990 | 10914 | OMIM:218000 | Agenesis of the corpus callosum with peripheral neuropathy | | | | 163 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SLC25A21 CL E G H | 89874 | 14411 | OMIM:618811 | MITOCHONDRIAL DNA DEPLETION SYNDROME 18; MTDPS18 | | | | | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SLC26A9 CL E G H | 115019 | 14469 | ORPHA:586 | Cystic fibrosis | | | | 5 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SLC34A2 CL E G H | 10568 | 11020 | ORPHA:60025 | Pulmonary alveolar microlithiasis | | | | 7 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SLC34A2 CL E G H | 10568 | 11020 | OMIM:265100 | Pulmonary alveolar microlithiasis | | | | 7 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SLC6A14 CL E G H | 11254 | 11047 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SLC9A3 CL E G H | 6550 | 11073 | ORPHA:586 | Cystic fibrosis | | | | 7 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SMARCB1 CL E G H | 6598 | 11103 | ORPHA:2495 | Meningioma | HP:0040284 - Very rare | | | 87 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SMARCE1 CL E G H | 6605 | 11109 | ORPHA:2495 | Meningioma | HP:0040284 - Very rare | | | 47 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SMO CL E G H | 6608 | 11119 | ORPHA:2495 | Meningioma | HP:0040284 - Very rare | | | 22 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SMPD1 CL E G H | 6609 | 11120 | OMIM:607616 | Niemann-pick disease, type B | | | | 164 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | STAC3 CL E G H | 246329 | 28423 | OMIM:255995 | Myopathy, congenital, bailey-bloch | | | | 14 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | STK36 CL E G H | 27148 | 17209 | OMIM:619436 | CILIARY DYSKINESIA, PRIMARY, 46; CILD46 | | | | 3 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | STX1A CL E G H | 6804 | 11433 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SUFU CL E G H | 51684 | 16466 | ORPHA:2495 | Meningioma | HP:0040284 - Very rare | | | 124 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SYNE1 CL E G H | 23345 | 17089 | OMIM:618484 | Arthrogryposis multiplex congenita, Myogenic type | | | | 1129 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | SYT2 CL E G H | 127833 | 11510 | OMIM:619461 | MYASTHENIC SYNDROME, CONGENITAL, 7B, PRESYNAPTIC, AUTOSOMAL RECESSIVE; CMS7B | | | | 4 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | TERT CL E G H | 7015 | 11730 | ORPHA:2495 | Meningioma | HP:0040284 - Very rare | | | 238 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | TERT CL E G H | 7015 | 11730 | OMIM:614742 | PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1; PFBMFT1 | | | | 238 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | TERT CL E G H | 7015 | 11730 | OMIM:178500 | Pulmonary fibrosis, idiopathic | | | | 238 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | TGFB1 CL E G H | 7040 | 11766 | OMIM:219700 | Cystic fibrosis | | | | 13 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | TGFB1 CL E G H | 7040 | 11766 | ORPHA:586 | Cystic fibrosis | | | | 13 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | TINF2 CL E G H | 26277 | 11824 | OMIM:613990 | Dyskeratosis congenita, autosomal dominant 3 | | | | 60 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | TNFRSF13B CL E G H | 23495 | 18153 | ORPHA:1572 | Common variable immunodeficiency | | | | 32 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | TNFRSF13C CL E G H | 115650 | 17755 | ORPHA:1572 | Common variable immunodeficiency | | | | 12 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | TNFSF12 CL E G H | 8742 | 11927 | ORPHA:1572 | Common variable immunodeficiency | | | | 1 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | TOR1A CL E G H | 1861 | 3098 | OMIM:618947 | ARTHROGRYPOSIS MULTIPLEX CONGENITA 5; AMC5 | | | | 47 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | TOR1AIP1 CL E G H | 26092 | 29456 | OMIM:617072 | Muscular dystrophy, limb-girdle, type 2Y | | | | 10 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | TPM2 CL E G H | 7169 | 12011 | ORPHA:171439 | Childhood-onset nemaline myopathy | | | | 54 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | TPM2 CL E G H | 7169 | 12011 | OMIM:255310 | Myopathy, congenital, with fiber-type disproportion | | | | 54 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | TPM2 CL E G H | 7169 | 12011 | OMIM:609285 | Nemaline myopathy 4 | | | | 54 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | TPM3 CL E G H | 7170 | 12012 | ORPHA:171439 | Childhood-onset nemaline myopathy | | | | 108 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | TPM3 CL E G H | 7170 | 12012 | OMIM:255310 | Myopathy, congenital, with fiber-type disproportion | | | | 108 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | TRAF7 CL E G H | 84231 | 20456 | ORPHA:2495 | Meningioma | HP:0040284 - Very rare | | | | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | TRAPPC11 CL E G H | 60684 | 25751 | ORPHA:369847 | Intellectual disability-hyperkinetic movement-truncal ataxia syndrome | | | | 27 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | TRNL1 CL E G H | 4567 | 7490 | ORPHA:663 | Mitochondrial DNA-related progressive external ophthalmoplegia | | | | | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | TRNL2 CL E G H | 4568 | 7491 | ORPHA:663 | Mitochondrial DNA-related progressive external ophthalmoplegia | | | | | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | TRNN CL E G H | 4570 | 7493 | ORPHA:663 | Mitochondrial DNA-related progressive external ophthalmoplegia | | | | | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | TRNS1 CL E G H | 4574 | 7497 | ORPHA:663 | Mitochondrial DNA-related progressive external ophthalmoplegia | | | | | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | TSC1 CL E G H | 7248 | 12362 | ORPHA:538 | Lymphangioleiomyomatosis | | | | 1090 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | TSC2 CL E G H | 7249 | 12363 | ORPHA:538 | Lymphangioleiomyomatosis | | | | 2738 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | TTN CL E G H | 7273 | 12403 | ORPHA:324604 | Classic multiminicore myopathy | | | | 7128 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | TTN CL E G H | 7273 | 12403 | ORPHA:178464 | Hereditary myopathy with early respiratory failure | | | | 7128 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | TTN CL E G H | 7273 | 12403 | OMIM:603689 | Myopathy, myofibrillar, 9, with early respiratory failure | | | | 7128 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | UNC45B CL E G H | 146862 | 14304 | OMIM:619178 | MYOFIBRILLAR MYOPATHY 11; MFM11 | | | | 1 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | VCP CL E G H | 7415 | 12666 | ORPHA:329478 | Adult-onset distal myopathy due to VCP mutation | | | | 63 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | WDR19 CL E G H | 57728 | 18340 | OMIM:614376 | Short-Rib thoracic dysplasia 5 with or without polydactyly | | | | 95 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | XYLT1 CL E G H | 64131 | 15516 | OMIM:264800 | PSEUDOXANTHOMA ELASTICUM; PXE | | | | 14 | | |
HP:0030878 | HP:0030878 | Abnormality on pulmonary function testing | 0 | XYLT2 CL E G H | 64132 | 15517 | OMIM:264800 | PSEUDOXANTHOMA ELASTICUM; PXE | | | | 5 | | |
HP:0030878 | HP:0033372 | Abnormal KCO | 1 | CL E G H | | | | | | | | | | |
HP:0030878 | HP:0033749 | Abnormal functional residual capacity | 1 | CL E G H | | | | | | | | | | |
HP:0030878 | HP:0033772 | Abnormal RV/TLC ratio | 1 | CL E G H | | | | | | | | | | |
HP:0030878 | HP:0033350 | Elevated forced expiratory volume in one second | 1 | CL E G H | | | | | | | | | | |
HP:0030878 | HP:0033760 | Decreased maximal oxygen uptake | 1 | CL E G H | | | | | | | | | | |
HP:0030878 | HP:0033632 | Abnormal alveolar volume | 1 | CL E G H | | | | | | | | | | |
HP:0030878 | HP:0032355 | Decreased peak expiratory flow | 1 | CL E G H | | | | | | | | | | |
HP:0030878 | HP:0033752 | Abnormal residual volume | 1 | CL E G H | | | | | | | | | | |
HP:0030878 | HP:0033169 | Reduced total lung capacity | 1 | CL E G H | | | | | | | | | | |
HP:0030878 | HP:0045049 | Abnormal DLCO | 1 | ABCC6 CL E G H | 368 | 57 | OMIM:264800 | PSEUDOXANTHOMA ELASTICUM; PXE | | | | 415 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | ACP5 CL E G H | 54 | 124 | OMIM:607944 | Spondyloenchondrodysplasia with immune dysregulation | . | | | 16 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | ACTA1 CL E G H | 58 | 129 | ORPHA:171439 | Childhood-onset nemaline myopathy | HP:0040283 - Occasional | | | 96 | | |
HP:0030878 | HP:0032341 | Reduced forced vital capacity | 1 | ACTA1 CL E G H | 58 | 129 | OMIM:255310 | Myopathy, congenital, with fiber-type disproportion | . | | | 96 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | ACTN2 CL E G H | 88 | 164 | OMIM:618654 | MYOPATHY, CONGENITAL, WITH STRUCTURED CORES AND Z-LINE ABNORMALITIES; MYOCOZ | | | | 307 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | AGRN CL E G H | 375790 | 329 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 127 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | AGRN CL E G H | 375790 | 329 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 127 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | AK9 CL E G H | 221264 | 33814 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 1 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | AK9 CL E G H | 221264 | 33814 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 1 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | ALMS1 CL E G H | 7840 | 428 | ORPHA:64 | Alström syndrome | HP:0040282 - Frequent | | | 404 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | ARSB CL E G H | 411 | 714 | OMIM:253200 | Mucopolysaccharidosis, type VI | | | | 120 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | B3GALT6 CL E G H | 126792 | 17978 | ORPHA:536467 | B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome | HP:0040283 - Occasional | | | 38 | | |
HP:0030878 | HP:0032341 | Reduced forced vital capacity | 1 | BAG3 CL E G H | 9531 | 939 | OMIM:612954 | Myopathy, myofibrillar, 6 | . | | | 204 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | BICD2 CL E G H | 23299 | 17208 | OMIM:615290 | Spinal muscular atrophy, lower extremity-predominant, 2, autosomaldominant | | | | 46 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | BTNL2 CL E G H | 56244 | 1142 | OMIM:612387 | Sarcoidosis, susceptibility to, 2 | | | | 1 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | CD19 CL E G H | 930 | 1633 | ORPHA:1572 | Common variable immunodeficiency | HP:0040283 - Occasional | | | 38 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | CD81 CL E G H | 975 | 1701 | ORPHA:1572 | Common variable immunodeficiency | HP:0040283 - Occasional | | | 1 | | |
HP:0030878 | HP:0032342 | Reduced forced expiratory volume in one second | 1 | CEACAM3 CL E G H | 1084 | 1815 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0030878 | HP:0032342 | Reduced forced expiratory volume in one second | 1 | CEACAM6 CL E G H | 4680 | 1818 | ORPHA:586 | Cystic fibrosis | | | | 1 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | CFAP410 CL E G H | 755 | 1260 | OMIM:602271 | Spondylometaphyseal dysplasia, axial | | | | | | |
HP:0030878 | HP:0032359 | Decreased forced expiratory flow 25-75% | 1 | CFTR CL E G H | 1080 | 1884 | OMIM:219700 | Cystic fibrosis | | | | 1371 | | |
HP:0030878 | HP:0032342 | Reduced forced expiratory volume in one second | 1 | CFTR CL E G H | 1080 | 1884 | OMIM:219700 | Cystic fibrosis | | | | 1371 | | |
HP:0030878 | HP:0032342 | Reduced forced expiratory volume in one second | 1 | CFTR CL E G H | 1080 | 1884 | ORPHA:586 | Cystic fibrosis | | | | 1371 | | |
HP:0030878 | HP:0032341 | Reduced forced vital capacity | 1 | CFTR CL E G H | 1080 | 1884 | OMIM:219700 | Cystic fibrosis | | | | 1371 | | |
HP:0030878 | HP:0030877 | Reduced FEV1/FVC ratio | 1 | CFTR CL E G H | 1080 | 1884 | ORPHA:60033 | Idiopathic bronchiectasis | HP:0040282 - Frequent | | | 1371 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | CHCHD10 CL E G H | 400916 | 15559 | ORPHA:457050 | Autosomal dominant mitochondrial myopathy with exercise intolerance | HP:0040282 - Frequent | | | 11 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | CHRNA1 CL E G H | 1134 | 1955 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 74 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | CHRNA1 CL E G H | 1134 | 1955 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 74 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | CHRNB1 CL E G H | 1140 | 1961 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 53 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | CHRNB1 CL E G H | 1140 | 1961 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 53 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | CHRND CL E G H | 1144 | 1965 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 88 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | CHRND CL E G H | 1144 | 1965 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 88 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | CHRNE CL E G H | 1145 | 1966 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 139 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | CHRNE CL E G H | 1145 | 1966 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 139 | | |
HP:0030878 | HP:0032342 | Reduced forced expiratory volume in one second | 1 | CLCA4 CL E G H | 22802 | 2018 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | COL13A1 CL E G H | 1305 | 2190 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 6 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | COL13A1 CL E G H | 1305 | 2190 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 6 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | COL2A1 CL E G H | 1280 | 2200 | OMIM:183900 | Spondyloepiphyseal dysplasia congenita | . | | | 284 | | |
HP:0030878 | HP:0032341 | Reduced forced vital capacity | 1 | COL6A2 CL E G H | 1292 | 2212 | OMIM:255600 | Myosclerosis, autosomal recessive | . | | | 478 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | COPA CL E G H | 1314 | 2230 | OMIM:616414 | AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE; AILJK | | | | 5 | | |
HP:0030878 | HP:0045049 | Abnormal DLCO | 1 | COPA CL E G H | 1314 | 2230 | OMIM:616414 | AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE; AILJK | | | | 5 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | CR2 CL E G H | 1380 | 2336 | ORPHA:1572 | Common variable immunodeficiency | HP:0040283 - Occasional | | | 10 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | CRPPA CL E G H | 729920 | 37276 | ORPHA:352479 | ISPD-related limb-girdle muscular dystrophy R20 | HP:0040282 - Frequent | | | | | |
HP:0030878 | HP:0032341 | Reduced forced vital capacity | 1 | CRPPA CL E G H | 729920 | 37276 | OMIM:616052 | Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7 | . | | | | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | CSF2RA CL E G H | 1438 | 2435 | ORPHA:264675 | Hereditary pulmonary alveolar proteinosis | HP:0040282 - Frequent | | | 15 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | CSF2RA CL E G H | 1438 | 2435 | OMIM:300770 | SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 4; SMDP4 | | | | 15 | | |
HP:0030878 | HP:0032342 | Reduced forced expiratory volume in one second | 1 | CSF2RA CL E G H | 1438 | 2435 | OMIM:300770 | SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 4; SMDP4 | | | | 15 | | |
HP:0030878 | HP:0032341 | Reduced forced vital capacity | 1 | CSF2RA CL E G H | 1438 | 2435 | OMIM:300770 | SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 4; SMDP4 | | | | 15 | | |
HP:0030878 | HP:0045049 | Abnormal DLCO | 1 | CSF2RA CL E G H | 1438 | 2435 | OMIM:300770 | SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 4; SMDP4 | | | | 15 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | CSF2RB CL E G H | 1439 | 2436 | ORPHA:264675 | Hereditary pulmonary alveolar proteinosis | HP:0040282 - Frequent | | | 17 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | CTLA4 CL E G H | 1493 | 2505 | ORPHA:900 | Granulomatosis with polyangiitis | HP:0040283 - Occasional | | | 10 | | |
HP:0030878 | HP:0032342 | Reduced forced expiratory volume in one second | 1 | DCTN4 CL E G H | 51164 | 15518 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | DDR2 CL E G H | 4921 | 2731 | OMIM:271665 | Spondylometaepiphyseal dysplasia, short Limb-Hand type | . | | | 45 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | DKC1 CL E G H | 1736 | 2890 | OMIM:305000 | Dyskeratosis congenita, X-linked | . | | | 65 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | DLK1 CL E G H | 8788 | 2907 | ORPHA:96334 | Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14 | HP:0040283 - Occasional | | | 1 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | DMD CL E G H | 1756 | 2928 | OMIM:310200 | Duchenne muscular dystrophy | | | | 1496 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | DNAH11 CL E G H | 8701 | 2942 | OMIM:611884 | CILIARY DYSKINESIA, PRIMARY, 7; CILD7 | | | | 542 | | |
HP:0030878 | HP:0030877 | Reduced FEV1/FVC ratio | 1 | DNAH11 CL E G H | 8701 | 2942 | OMIM:611884 | CILIARY DYSKINESIA, PRIMARY, 7; CILD7 | | | | 542 | | |
HP:0030878 | HP:0032342 | Reduced forced expiratory volume in one second | 1 | DNAH9 CL E G H | 1770 | 2953 | OMIM:618300 | Ciliary dyskinesia, primary, 40 | | | | 18 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | DNASE1L3 CL E G H | 1776 | 2959 | ORPHA:36412 | Hypocomplementemic urticarial vasculitis | HP:0040283 - Occasional | | | 3 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | DOK7 CL E G H | 285489 | 26594 | OMIM:254300 | Myasthenia, limb-girdle, familial | | | | 91 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | DOK7 CL E G H | 285489 | 26594 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 91 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | DOK7 CL E G H | 285489 | 26594 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 91 | | |
HP:0030878 | HP:0032342 | Reduced forced expiratory volume in one second | 1 | EDNRA CL E G H | 1909 | 3179 | ORPHA:586 | Cystic fibrosis | | | | 3 | | |
HP:0030878 | HP:0045049 | Abnormal DLCO | 1 | EIF2AK4 CL E G H | 440275 | 19687 | ORPHA:199241 | Pulmonary capillary hemangiomatosis | | | | 40 | | |
HP:0030878 | HP:0045049 | Abnormal DLCO | 1 | EIF2AK4 CL E G H | 440275 | 19687 | OMIM:234810 | PULMONARY VENOOCCLUSIVE DISEASE 2, AUTOSOMAL RECESSIVE; PVOD2 | | | | 40 | | |
HP:0030878 | HP:0030877 | Reduced FEV1/FVC ratio | 1 | ENG CL E G H | 2022 | 3349 | OMIM:187300 | Telangiectasia, hereditary hemorrhagic, type 1 | | | | 186 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | ENG CL E G H | 2022 | 3349 | OMIM:187300 | Telangiectasia, hereditary hemorrhagic, type 1 | | | | 186 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | FARSA CL E G H | 2193 | 3592 | OMIM:619013 | RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS 2; RILDBC2 | | | | | | |
HP:0030878 | HP:0032341 | Reduced forced vital capacity | 1 | FCGR2A CL E G H | 2212 | 3616 | OMIM:219700 | Cystic fibrosis | | | | 6 | | |
HP:0030878 | HP:0032359 | Decreased forced expiratory flow 25-75% | 1 | FCGR2A CL E G H | 2212 | 3616 | OMIM:219700 | Cystic fibrosis | | | | 6 | | |
HP:0030878 | HP:0032342 | Reduced forced expiratory volume in one second | 1 | FCGR2A CL E G H | 2212 | 3616 | OMIM:219700 | Cystic fibrosis | | | | 6 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | FGFR3 CL E G H | 2261 | 3690 | ORPHA:15 | Achondroplasia | HP:0040283 - Occasional | | | 145 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | FKRP CL E G H | 79147 | 17997 | OMIM:606612 | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5 | . | | | 157 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | FKRP CL E G H | 79147 | 17997 | OMIM:607155 | Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5 | . | | | 157 | | |
HP:0030878 | HP:0032341 | Reduced forced vital capacity | 1 | FKRP CL E G H | 79147 | 17997 | OMIM:607155 | Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5 | . | | | 157 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | FLNB CL E G H | 2317 | 3755 | OMIM:272460 | Spondylocarpotarsal synostosis syndrome | . | | | 233 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | FRG1 CL E G H | 2483 | 3954 | OMIM:158900 | Facioscapulohumeral muscular dystrophy 1 | . | | | 1 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | GALNS CL E G H | 2588 | 4122 | OMIM:253000 | Morquio syndrome A | . | | | 123 | | |
HP:0030878 | HP:0032342 | Reduced forced expiratory volume in one second | 1 | GCLC CL E G H | 2729 | 4311 | ORPHA:586 | Cystic fibrosis | | | | 2 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | GDAP1 CL E G H | 54332 | 15968 | ORPHA:99948 | Charcot-Marie-Tooth disease type 4A | | | | 108 | | |
HP:0030878 | HP:0032341 | Reduced forced vital capacity | 1 | GGPS1 CL E G H | 9453 | 4249 | OMIM:619518 | MUSCULAR DYSTROPHY, CONGENITAL HEARING LOSS, AND OVARIAN INSUFFICIENCY SYNDROME; MDHLO | | | | | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | GIPC1 CL E G H | 10755 | 1226 | ORPHA:98897 | Oculopharyngodistal myopathy | HP:0040283 - Occasional | | | | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | GLB1 CL E G H | 2720 | 4298 | OMIM:253010 | Mucopolysaccharidosis type IVB (Morquio) | . | | | 120 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | GNPTAB CL E G H | 79158 | 29670 | ORPHA:576 | Mucolipidosis type II | HP:0040282 - Frequent | | | 240 | | |
HP:0030878 | HP:0032342 | Reduced forced expiratory volume in one second | 1 | GSTM3 CL E G H | 2947 | 4635 | ORPHA:586 | Cystic fibrosis | | | | 1 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | GZF1 CL E G H | 64412 | 15808 | OMIM:617662 | Joint laxity, short stature, and myopia | . | | | | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | HES7 CL E G H | 84667 | 15977 | OMIM:613686 | Spondylocostal dysostosis 4, autosomal recessive | . | | | 10 | | |
HP:0030878 | HP:0032342 | Reduced forced expiratory volume in one second | 1 | HFE CL E G H | 3077 | 4886 | ORPHA:586 | Cystic fibrosis | | | | 38 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | HLA-B CL E G H | 3106 | 4932 | ORPHA:36426 | Stevens-Johnson syndrome | HP:0040283 - Occasional | | | 4 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | HLA-DPA1 CL E G H | 3113 | 4938 | ORPHA:900 | Granulomatosis with polyangiitis | HP:0040283 - Occasional | | | | | |
HP:0030878 | HP:0030877 | Reduced FEV1/FVC ratio | 1 | HLA-DPB1 CL E G H | 3115 | 4940 | ORPHA:133 | Chronic beryllium disease | HP:0040282 - Frequent | | | 1 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | HLA-DPB1 CL E G H | 3115 | 4940 | ORPHA:900 | Granulomatosis with polyangiitis | HP:0040283 - Occasional | | | 1 | | |
HP:0030878 | HP:0045049 | Abnormal DLCO | 1 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:747 | Autoimmune pulmonary alveolar proteinosis | | | | 2 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:747 | Autoimmune pulmonary alveolar proteinosis | HP:0040282 - Frequent | | | 2 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | HLA-DRB1 CL E G H | 3123 | 4948 | OMIM:181000 | Sarcoidosis, susceptibility to, 1 | | | | 2 | | |
HP:0030878 | HP:0032342 | Reduced forced expiratory volume in one second | 1 | HMOX1 CL E G H | 3162 | 5013 | ORPHA:586 | Cystic fibrosis | | | | 3 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | HPS1 CL E G H | 3257 | 5163 | OMIM:203300 | Hermansky-Pudlak syndrome 1 | . | | | 121 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | HPS4 CL E G H | 89781 | 15844 | OMIM:614073 | Hermansky-Pudlak syndrome 4 | . | | | 123 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | ICOS CL E G H | 29851 | 5351 | ORPHA:1572 | Common variable immunodeficiency | HP:0040283 - Occasional | | | 32 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | IDS CL E G H | 3423 | 5389 | ORPHA:217093 | Mucopolysaccharidosis type 2, attenuated form | HP:0040283 - Occasional | | | 86 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | IDS CL E G H | 3423 | 5389 | ORPHA:217085 | Mucopolysaccharidosis type 2, severe form | HP:0040283 - Occasional | | | 86 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | IKZF1 CL E G H | 10320 | 13176 | ORPHA:36426 | Stevens-Johnson syndrome | HP:0040283 - Occasional | | | 8 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | IRF2BP2 CL E G H | 359948 | 21729 | ORPHA:1572 | Common variable immunodeficiency | HP:0040283 - Occasional | | | 4 | | |
HP:0030878 | HP:0032342 | Reduced forced expiratory volume in one second | 1 | ITCH CL E G H | 83737 | 13890 | OMIM:613385 | AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD | | | | 3 | | |
HP:0030878 | HP:0032341 | Reduced forced vital capacity | 1 | JAG2 CL E G H | 3714 | 6189 | OMIM:619566 | MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 27; LGMDR27 | | | | 1 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | KBTBD13 CL E G H | 390594 | 37227 | ORPHA:171439 | Childhood-onset nemaline myopathy | HP:0040283 - Occasional | | | 80 | | |
HP:0030878 | HP:0032342 | Reduced forced expiratory volume in one second | 1 | KCNN4 CL E G H | 3783 | 6293 | ORPHA:586 | Cystic fibrosis | | | | 3 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | KLHL41 CL E G H | 10324 | 16905 | ORPHA:171439 | Childhood-onset nemaline myopathy | HP:0040283 - Occasional | | | 13 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | LRP12 CL E G H | 29967 | 31708 | OMIM:164310 | Oculopharyngodistal myopathy 1 | . | | | | | |
HP:0030878 | HP:0032341 | Reduced forced vital capacity | 1 | LRP12 CL E G H | 29967 | 31708 | OMIM:164310 | Oculopharyngodistal myopathy 1 | | | | | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | LRP4 CL E G H | 4038 | 6696 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 124 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | LRP4 CL E G H | 4038 | 6696 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 124 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | MAP3K20 CL E G H | 51776 | 17797 | OMIM:617760 | Myopathy, centronuclear, 6, with fiber-type disproportion | . | | | 2 | | |
HP:0030878 | HP:0032341 | Reduced forced vital capacity | 1 | MCIDAS CL E G H | 345643 | 40050 | OMIM:618695 | CILIARY DYSKINESIA, PRIMARY, 42; CILD42 | | | | 13 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | MEG3 CL E G H | 55384 | 14575 | ORPHA:96334 | Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14 | HP:0040283 - Occasional | | | 1 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | MEGF10 CL E G H | 84466 | 29634 | OMIM:614399 | Myopathy, areflexia, respiratory distress, and dysphagia, early-onset | . | | | 158 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | MESP2 CL E G H | 145873 | 29659 | OMIM:608681 | Spondylocostal dysostosis 2, autosomal recessive | | | | 45 | | |
HP:0030878 | HP:0032342 | Reduced forced expiratory volume in one second | 1 | MIF CL E G H | 4282 | 7097 | ORPHA:586 | Cystic fibrosis | | | | 1 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | MS4A1 CL E G H | 931 | 7315 | ORPHA:1572 | Common variable immunodeficiency | HP:0040283 - Occasional | | | 1 | | |
HP:0030878 | HP:0045049 | Abnormal DLCO | 1 | MUC5B CL E G H | 727897 | 7516 | OMIM:178500 | Pulmonary fibrosis, idiopathic | | | | 133 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | MUSK CL E G H | 4593 | 7525 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 72 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | MUSK CL E G H | 4593 | 7525 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 72 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | MYH7 CL E G H | 4625 | 7577 | ORPHA:324604 | Classic multiminicore myopathy | HP:0040282 - Frequent | | | 1269 | | |
HP:0030878 | HP:0032341 | Reduced forced vital capacity | 1 | MYH7 CL E G H | 4625 | 7577 | OMIM:255310 | Myopathy, congenital, with fiber-type disproportion | . | | | 1269 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | MYH7 CL E G H | 4625 | 7577 | OMIM:608358 | Myopathy, myosin storage | . | | | 1269 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | MYH7 CL E G H | 4625 | 7577 | OMIM:255160 | Myopathy, myosin storage, autosomal recessive | | | | 1269 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | MYO1H CL E G H | 283446 | 13879 | OMIM:619482 | CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL, 2, AND AUTONOMIC DYSFUNCTION; CCHS2 | | | | | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | MYOT CL E G H | 9499 | 12399 | ORPHA:266 | Autosomal dominant limb-girdle muscular dystrophy type 1A | HP:0040283 - Occasional | | | 75 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | MYPN CL E G H | 84665 | 23246 | ORPHA:171439 | Childhood-onset nemaline myopathy | HP:0040283 - Occasional | | | 217 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | MYPN CL E G H | 84665 | 23246 | OMIM:617336 | Nemaline myopathy 11, autosomal recessive | HP:0040283 - Occasional | | | 217 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | NAA10 CL E G H | 8260 | 18704 | OMIM:300855 | Ogden syndrome | | | | 23 | | |
HP:0030878 | HP:0045049 | Abnormal DLCO | 1 | NDUFAF6 CL E G H | 137682 | 28625 | OMIM:618913 | FANCONI RENOTUBULAR SYNDROME 5; FRTS5 | | | | 39 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | NEB CL E G H | 4703 | 7720 | ORPHA:171439 | Childhood-onset nemaline myopathy | HP:0040283 - Occasional | | | 745 | | |
HP:0030878 | HP:0032342 | Reduced forced expiratory volume in one second | 1 | NEK10 CL E G H | 152110 | 18592 | OMIM:618781 | CILIARY DYSKINESIA, PRIMARY, 44; CILD44 | | | | | | |
HP:0030878 | HP:0032341 | Reduced forced vital capacity | 1 | NEK10 CL E G H | 152110 | 18592 | OMIM:618781 | CILIARY DYSKINESIA, PRIMARY, 44; CILD44 | | | | | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | NFKB1 CL E G H | 4790 | 7794 | ORPHA:1572 | Common variable immunodeficiency | HP:0040283 - Occasional | | | 7 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | NFKB2 CL E G H | 4791 | 7795 | ORPHA:1572 | Common variable immunodeficiency | HP:0040283 - Occasional | | | 11 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | NKX2-1 CL E G H | 7080 | 11825 | OMIM:610978 | Choreoathetosis, hypothyroidism, and neonatal respiratory distress | | | | 51 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | NLRP3 CL E G H | 114548 | 16400 | ORPHA:575 | Muckle-Wells syndrome | HP:0040283 - Occasional | | | 217 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | NOTCH2NLC CL E G H | 100996717 | 53924 | ORPHA:98897 | Oculopharyngodistal myopathy | HP:0040283 - Occasional | | | | | |
HP:0030878 | HP:0032342 | Reduced forced expiratory volume in one second | 1 | PARN CL E G H | 5073 | 8609 | OMIM:616371 | PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 4; PFBMFT4 | | | | 26 | | |
HP:0030878 | HP:0045049 | Abnormal DLCO | 1 | PARN CL E G H | 5073 | 8609 | OMIM:616371 | PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 4; PFBMFT4 | | | | 26 | | |
HP:0030878 | HP:0032341 | Reduced forced vital capacity | 1 | PARN CL E G H | 5073 | 8609 | OMIM:616371 | PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 4; PFBMFT4 | | | | 26 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | PIEZO2 CL E G H | 63895 | 26270 | OMIM:108145 | Arthrogryposis, distal, type 5 | . | | | 77 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | PLOD1 CL E G H | 5351 | 9081 | ORPHA:1900 | Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency | HP:0040284 - Very rare | | | 105 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | PRKCD CL E G H | 5580 | 9399 | ORPHA:1572 | Common variable immunodeficiency | HP:0040283 - Occasional | | | 10 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | PRTN3 CL E G H | 5657 | 9495 | ORPHA:900 | Granulomatosis with polyangiitis | HP:0040283 - Occasional | | | | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | PTPN22 CL E G H | 26191 | 9652 | ORPHA:900 | Granulomatosis with polyangiitis | HP:0040283 - Occasional | | | 3 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | PYROXD1 CL E G H | 79912 | 26162 | OMIM:617258 | MYOPATHY, MYOFIBRILLAR, 8; MFM8 | | | | 5 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | PYROXD1 CL E G H | 79912 | 26162 | OMIM:617258 | MYOPATHY, MYOFIBRILLAR, 8; MFM8 | | | | 5 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | RAPSN CL E G H | 5913 | 9863 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 73 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | RAPSN CL E G H | 5913 | 9863 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 73 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | RNF168 CL E G H | 165918 | 26661 | ORPHA:420741 | RIDDLE syndrome | HP:0040283 - Occasional | | | 7 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | RNU4ATAC CL E G H | 100151683 | 34016 | OMIM:226960 | EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS | | | | 15 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | RPA1 CL E G H | 6117 | 10289 | OMIM:619767 | PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 6; PFBMFT6 | | | | | | |
HP:0030878 | HP:0032342 | Reduced forced expiratory volume in one second | 1 | RTEL1 CL E G H | 51750 | 15888 | OMIM:616373 | PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 3; PFBMFT3 | | | | 77 | | |
HP:0030878 | HP:0045049 | Abnormal DLCO | 1 | RTEL1 CL E G H | 51750 | 15888 | OMIM:616373 | PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 3; PFBMFT3 | | | | 77 | | |
HP:0030878 | HP:0032341 | Reduced forced vital capacity | 1 | RTEL1 CL E G H | 51750 | 15888 | OMIM:616373 | PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 3; PFBMFT3 | | | | 77 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | RTL1 CL E G H | 388015 | 14665 | ORPHA:96334 | Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14 | HP:0040283 - Occasional | | | | | |
HP:0030878 | HP:0032341 | Reduced forced vital capacity | 1 | RYR1 CL E G H | 6261 | 10483 | OMIM:255310 | Myopathy, congenital, with fiber-type disproportion | . | | | 1200 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | SBF2 CL E G H | 81846 | 2135 | ORPHA:99956 | Charcot-Marie-Tooth disease type 4B2 | | | | 180 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | SCN4A CL E G H | 6329 | 10591 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 263 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | SCN4A CL E G H | 6329 | 10591 | ORPHA:98913 | Postsynaptic congenital myasthenic syndromes | HP:0040283 - Occasional | | | 263 | | |
HP:0030878 | HP:0030877 | Reduced FEV1/FVC ratio | 1 | SCNN1A CL E G H | 6337 | 10599 | ORPHA:60033 | Idiopathic bronchiectasis | HP:0040282 - Frequent | | | 67 | | |
HP:0030878 | HP:0030877 | Reduced FEV1/FVC ratio | 1 | SCNN1B CL E G H | 6338 | 10600 | ORPHA:60033 | Idiopathic bronchiectasis | HP:0040282 - Frequent | | | 61 | | |
HP:0030878 | HP:0030877 | Reduced FEV1/FVC ratio | 1 | SCNN1G CL E G H | 6340 | 10602 | ORPHA:60033 | Idiopathic bronchiectasis | HP:0040282 - Frequent | | | 57 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | SELENON CL E G H | 57190 | 15999 | ORPHA:324604 | Classic multiminicore myopathy | HP:0040282 - Frequent | | | 144 | | |
HP:0030878 | HP:0032341 | Reduced forced vital capacity | 1 | SELENON CL E G H | 57190 | 15999 | OMIM:255310 | Myopathy, congenital, with fiber-type disproportion | . | | | 144 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | SELENON CL E G H | 57190 | 15999 | OMIM:602771 | Rigid spine muscular dystrophy 1 | . | | | 144 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | SELENON CL E G H | 57190 | 15999 | OMIM:602771 | Rigid spine muscular dystrophy 1 | . | | | 144 | | |
HP:0030878 | HP:0032342 | Reduced forced expiratory volume in one second | 1 | SERPINA1 CL E G H | 5265 | 8941 | ORPHA:586 | Cystic fibrosis | | | | 131 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | SFTPA1 CL E G H | 653509 | 10798 | OMIM:619611 | INTERSTITIAL LUNG DISEASE 1; ILD1 | | | | 19 | | |
HP:0030878 | HP:0045049 | Abnormal DLCO | 1 | SFTPA1 CL E G H | 653509 | 10798 | OMIM:619611 | INTERSTITIAL LUNG DISEASE 1; ILD1 | | | | 19 | | |
HP:0030878 | HP:0045049 | Abnormal DLCO | 1 | SFTPA2 CL E G H | 729238 | 10799 | OMIM:178500 | Pulmonary fibrosis, idiopathic | | | | 10 | | |
HP:0030878 | HP:0045049 | Abnormal DLCO | 1 | SFTPC CL E G H | 6440 | 10802 | OMIM:178500 | Pulmonary fibrosis, idiopathic | | | | 33 | | |
HP:0030878 | HP:0032341 | Reduced forced vital capacity | 1 | SFTPC CL E G H | 6440 | 10802 | OMIM:610913 | Surfactant metabolism dysfunction, pulmonary, 2 | | | | 33 | | |
HP:0030878 | HP:0045049 | Abnormal DLCO | 1 | SFTPC CL E G H | 6440 | 10802 | OMIM:610913 | Surfactant metabolism dysfunction, pulmonary, 2 | | | | 33 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | SGCG CL E G H | 6445 | 10809 | OMIM:253700 | Muscular dystrophy, limb-girdle, type 2C | . | | | 83 | | |
HP:0030878 | HP:0032342 | Reduced forced expiratory volume in one second | 1 | SLC11A1 CL E G H | 6556 | 10907 | ORPHA:586 | Cystic fibrosis | | | | 2 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | SLC12A6 CL E G H | 9990 | 10914 | OMIM:218000 | Agenesis of the corpus callosum with peripheral neuropathy | . | | | 163 | | |
HP:0030878 | HP:0032341 | Reduced forced vital capacity | 1 | SLC25A21 CL E G H | 89874 | 14411 | OMIM:618811 | MITOCHONDRIAL DNA DEPLETION SYNDROME 18; MTDPS18 | | | | | | |
HP:0030878 | HP:0032342 | Reduced forced expiratory volume in one second | 1 | SLC26A9 CL E G H | 115019 | 14469 | ORPHA:586 | Cystic fibrosis | | | | 5 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | SLC34A2 CL E G H | 10568 | 11020 | OMIM:265100 | Pulmonary alveolar microlithiasis | . | | | 7 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | SLC34A2 CL E G H | 10568 | 11020 | ORPHA:60025 | Pulmonary alveolar microlithiasis | HP:0040282 - Frequent | | | 7 | | |
HP:0030878 | HP:0032342 | Reduced forced expiratory volume in one second | 1 | SLC6A14 CL E G H | 11254 | 11047 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0030878 | HP:0032342 | Reduced forced expiratory volume in one second | 1 | SLC9A3 CL E G H | 6550 | 11073 | ORPHA:586 | Cystic fibrosis | | | | 7 | | |
HP:0030878 | HP:0045049 | Abnormal DLCO | 1 | SMPD1 CL E G H | 6609 | 11120 | OMIM:607616 | Niemann-pick disease, type B | | | | 164 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | STAC3 CL E G H | 246329 | 28423 | OMIM:255995 | Myopathy, congenital, bailey-bloch | . | | | 14 | | |
HP:0030878 | HP:0032341 | Reduced forced vital capacity | 1 | STK36 CL E G H | 27148 | 17209 | OMIM:619436 | CILIARY DYSKINESIA, PRIMARY, 46; CILD46 | | | | 3 | | |
HP:0030878 | HP:0032342 | Reduced forced expiratory volume in one second | 1 | STK36 CL E G H | 27148 | 17209 | OMIM:619436 | CILIARY DYSKINESIA, PRIMARY, 46; CILD46 | | | | 3 | | |
HP:0030878 | HP:0032342 | Reduced forced expiratory volume in one second | 1 | STX1A CL E G H | 6804 | 11433 | ORPHA:586 | Cystic fibrosis | | | | | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | SYNE1 CL E G H | 23345 | 17089 | OMIM:618484 | Arthrogryposis multiplex congenita, Myogenic type | HP:0040284 - Very rare | | | 1129 | | |
HP:0030878 | HP:0032341 | Reduced forced vital capacity | 1 | SYT2 CL E G H | 127833 | 11510 | OMIM:619461 | MYASTHENIC SYNDROME, CONGENITAL, 7B, PRESYNAPTIC, AUTOSOMAL RECESSIVE; CMS7B | | | | 4 | | |
HP:0030878 | HP:0045049 | Abnormal DLCO | 1 | TERT CL E G H | 7015 | 11730 | OMIM:614742 | PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1; PFBMFT1 | | | | 238 | | |
HP:0030878 | HP:0045049 | Abnormal DLCO | 1 | TERT CL E G H | 7015 | 11730 | OMIM:178500 | Pulmonary fibrosis, idiopathic | | | | 238 | | |
HP:0030878 | HP:0032341 | Reduced forced vital capacity | 1 | TGFB1 CL E G H | 7040 | 11766 | OMIM:219700 | Cystic fibrosis | | | | 13 | | |
HP:0030878 | HP:0032359 | Decreased forced expiratory flow 25-75% | 1 | TGFB1 CL E G H | 7040 | 11766 | OMIM:219700 | Cystic fibrosis | | | | 13 | | |
HP:0030878 | HP:0032342 | Reduced forced expiratory volume in one second | 1 | TGFB1 CL E G H | 7040 | 11766 | OMIM:219700 | Cystic fibrosis | | | | 13 | | |
HP:0030878 | HP:0032342 | Reduced forced expiratory volume in one second | 1 | TGFB1 CL E G H | 7040 | 11766 | ORPHA:586 | Cystic fibrosis | | | | 13 | | |
HP:0030878 | HP:0045049 | Abnormal DLCO | 1 | TINF2 CL E G H | 26277 | 11824 | OMIM:613990 | Dyskeratosis congenita, autosomal dominant 3 | | | | 60 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | TNFRSF13B CL E G H | 23495 | 18153 | ORPHA:1572 | Common variable immunodeficiency | HP:0040283 - Occasional | | | 32 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | TNFRSF13C CL E G H | 115650 | 17755 | ORPHA:1572 | Common variable immunodeficiency | HP:0040283 - Occasional | | | 12 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | TNFSF12 CL E G H | 8742 | 11927 | ORPHA:1572 | Common variable immunodeficiency | HP:0040283 - Occasional | | | 1 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | TOR1A CL E G H | 1861 | 3098 | OMIM:618947 | ARTHROGRYPOSIS MULTIPLEX CONGENITA 5; AMC5 | | | | 47 | | |
HP:0030878 | HP:0032359 | Decreased forced expiratory flow 25-75% | 1 | TOR1AIP1 CL E G H | 26092 | 29456 | OMIM:617072 | Muscular dystrophy, limb-girdle, type 2Y | | | | 10 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | TPM2 CL E G H | 7169 | 12011 | ORPHA:171439 | Childhood-onset nemaline myopathy | HP:0040283 - Occasional | | | 54 | | |
HP:0030878 | HP:0032341 | Reduced forced vital capacity | 1 | TPM2 CL E G H | 7169 | 12011 | OMIM:255310 | Myopathy, congenital, with fiber-type disproportion | . | | | 54 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | TPM2 CL E G H | 7169 | 12011 | OMIM:609285 | Nemaline myopathy 4 | . | | | 54 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | TPM3 CL E G H | 7170 | 12012 | ORPHA:171439 | Childhood-onset nemaline myopathy | HP:0040283 - Occasional | | | 108 | | |
HP:0030878 | HP:0032341 | Reduced forced vital capacity | 1 | TPM3 CL E G H | 7170 | 12012 | OMIM:255310 | Myopathy, congenital, with fiber-type disproportion | . | | | 108 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | TRAPPC11 CL E G H | 60684 | 25751 | ORPHA:369847 | Intellectual disability-hyperkinetic movement-truncal ataxia syndrome | HP:0040283 - Occasional | | | 27 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | TRNL1 CL E G H | 4567 | 7490 | ORPHA:663 | Mitochondrial DNA-related progressive external ophthalmoplegia | HP:0040282 - Frequent | | | | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | TRNL2 CL E G H | 4568 | 7491 | ORPHA:663 | Mitochondrial DNA-related progressive external ophthalmoplegia | HP:0040282 - Frequent | | | | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | TRNN CL E G H | 4570 | 7493 | ORPHA:663 | Mitochondrial DNA-related progressive external ophthalmoplegia | HP:0040282 - Frequent | | | | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | TRNS1 CL E G H | 4574 | 7497 | ORPHA:663 | Mitochondrial DNA-related progressive external ophthalmoplegia | HP:0040282 - Frequent | | | | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | TSC1 CL E G H | 7248 | 12362 | ORPHA:538 | Lymphangioleiomyomatosis | HP:0040281 - Very frequent | | | 1090 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | TSC2 CL E G H | 7249 | 12363 | ORPHA:538 | Lymphangioleiomyomatosis | HP:0040281 - Very frequent | | | 2738 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | TTN CL E G H | 7273 | 12403 | ORPHA:324604 | Classic multiminicore myopathy | HP:0040282 - Frequent | | | 7128 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | TTN CL E G H | 7273 | 12403 | ORPHA:178464 | Hereditary myopathy with early respiratory failure | HP:0040282 - Frequent | | | 7128 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | TTN CL E G H | 7273 | 12403 | ORPHA:178464 | Hereditary myopathy with early respiratory failure | HP:0040282 - Frequent | | | 7128 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | TTN CL E G H | 7273 | 12403 | OMIM:603689 | Myopathy, myofibrillar, 9, with early respiratory failure | | | | 7128 | | |
HP:0030878 | HP:0032341 | Reduced forced vital capacity | 1 | UNC45B CL E G H | 146862 | 14304 | OMIM:619178 | MYOFIBRILLAR MYOPATHY 11; MFM11 | | | | 1 | | |
HP:0030878 | HP:0002792 | Reduced vital capacity | 1 | VCP CL E G H | 7415 | 12666 | ORPHA:329478 | Adult-onset distal myopathy due to VCP mutation | HP:0040284 - Very rare | | | 63 | | |
HP:0030878 | HP:0002091 | Restrictive ventilatory defect | 1 | WDR19 CL E G H | 57728 | 18340 | OMIM:614376 | Short-Rib thoracic dysplasia 5 with or without polydactyly | | | | 95 | | |
HP:0030878 | HP:0045049 | Abnormal DLCO | 1 | XYLT1 CL E G H | 64131 | 15516 | OMIM:264800 | PSEUDOXANTHOMA ELASTICUM; PXE | | | | 14 | | |
HP:0030878 | HP:0045049 | Abnormal DLCO | 1 | XYLT2 CL E G H | 64132 | 15517 | OMIM:264800 | PSEUDOXANTHOMA ELASTICUM; PXE | | | | 5 | | |
HP:0030878 | HP:0033374 | Decreased KCO | 2 | CL E G H | | | | | | | | | | |
HP:0030878 | HP:0033751 | Elevated functional residual capacity | 2 | CL E G H | | | | | | | | | | |
HP:0030878 | HP:0032361 | Decreased post-bronchodilator forced expiratory flow 25-75% | 2 | CL E G H | | | | | | | | | | |
HP:0030878 | HP:0045050 | Increased DLCO | 2 | CL E G H | | | | | | | | | | |
HP:0030878 | HP:0033373 | Increased KCO | 2 | CL E G H | | | | | | | | | | |
HP:0030878 | HP:0033750 | Reduced functional residual capacity | 2 | CL E G H | | | | | | | | | | |
HP:0030878 | HP:0032360 | Decreased pre-bronchodilator forced expiratory flow 25-75% | 2 | CL E G H | | | | | | | | | | |
HP:0030878 | HP:0033773 | Decreased RV/TLC ratio | 2 | CL E G H | | | | | | | | | | |
HP:0030878 | HP:0032358 | Decreased post-bronchodilator forced expiratory volume in one second | 2 | CL E G H | | | | | | | | | | |
HP:0030878 | HP:0033634 | Increased alveolar volume | 2 | CL E G H | | | | | | | | | | |
HP:0030878 | HP:0032357 | Decreased post-bronchodilator forced vital capacity | 2 | CL E G H | | | | | | | | | | |
HP:0030878 | HP:0033251 | Elevated residual volume | 2 | CL E G H | | | | | | | | | | |
HP:0030878 | HP:0033633 | Decreased alveolar volume | 2 | CL E G H | | | | | | | | | | |
HP:0030878 | HP:0032356 | Decreased pre-bronchodilator forced vital capacity | 2 | CL E G H | | | | | | | | | | |
HP:0030878 | HP:0033753 | Reduced residual volume | 2 | CL E G H | | | | | | | | | | |
HP:0030878 | HP:0033240 | Elevated RV/TLC ratio | 2 | CL E G H | | | | | | | | | | |
HP:0030878 | HP:0045051 | Decreased DLCO | 2 | ABCC6 CL E G H | 368 | 57 | OMIM:264800 | PSEUDOXANTHOMA ELASTICUM; PXE | | | | 415 | | |
HP:0030878 | HP:0045051 | Decreased DLCO | 2 | COPA CL E G H | 1314 | 2230 | OMIM:616414 | AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE; AILJK | | | | 5 | | |
HP:0030878 | HP:0045051 | Decreased DLCO | 2 | CSF2RA CL E G H | 1438 | 2435 | OMIM:300770 | SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 4; SMDP4 | | | | 15 | | |
HP:0030878 | HP:0045051 | Decreased DLCO | 2 | EIF2AK4 CL E G H | 440275 | 19687 | ORPHA:199241 | Pulmonary capillary hemangiomatosis | HP:0040281 - Very frequent | | | 40 | | |
HP:0030878 | HP:0045051 | Decreased DLCO | 2 | EIF2AK4 CL E G H | 440275 | 19687 | OMIM:234810 | PULMONARY VENOOCCLUSIVE DISEASE 2, AUTOSOMAL RECESSIVE; PVOD2 | | | | 40 | | |
HP:0030878 | HP:0045051 | Decreased DLCO | 2 | HLA-DRB1 CL E G H | 3123 | 4948 | ORPHA:747 | Autoimmune pulmonary alveolar proteinosis | HP:0040282 - Frequent | | | 2 | | |
HP:0030878 | HP:0045051 | Decreased DLCO | 2 | MUC5B CL E G H | 727897 | 7516 | OMIM:178500 | Pulmonary fibrosis, idiopathic | | | | 133 | | |
HP:0030878 | HP:0045051 | Decreased DLCO | 2 | NDUFAF6 CL E G H | 137682 | 28625 | OMIM:618913 | FANCONI RENOTUBULAR SYNDROME 5; FRTS5 | | | | 39 | | |
HP:0030878 | HP:0045051 | Decreased DLCO | 2 | PARN CL E G H | 5073 | 8609 | OMIM:616371 | PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 4; PFBMFT4 | | | | 26 | | |
HP:0030878 | HP:0045051 | Decreased DLCO | 2 | RTEL1 CL E G H | 51750 | 15888 | OMIM:616373 | PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 3; PFBMFT3 | | | | 77 | | |
HP:0030878 | HP:0045051 | Decreased DLCO | 2 | SFTPA1 CL E G H | 653509 | 10798 | OMIM:619611 | INTERSTITIAL LUNG DISEASE 1; ILD1 | | | | 19 | | |
HP:0030878 | HP:0045051 | Decreased DLCO | 2 | SFTPA2 CL E G H | 729238 | 10799 | OMIM:178500 | Pulmonary fibrosis, idiopathic | | | | 10 | | |
HP:0030878 | HP:0045051 | Decreased DLCO | 2 | SFTPC CL E G H | 6440 | 10802 | OMIM:178500 | Pulmonary fibrosis, idiopathic | | | | 33 | | |
HP:0030878 | HP:0045051 | Decreased DLCO | 2 | SFTPC CL E G H | 6440 | 10802 | OMIM:610913 | Surfactant metabolism dysfunction, pulmonary, 2 | | | | 33 | | |
HP:0030878 | HP:0045051 | Decreased DLCO | 2 | SMPD1 CL E G H | 6609 | 11120 | OMIM:607616 | Niemann-pick disease, type B | | | | 164 | | |
HP:0030878 | HP:0045051 | Decreased DLCO | 2 | TERT CL E G H | 7015 | 11730 | OMIM:614742 | PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1; PFBMFT1 | | | | 238 | | |
HP:0030878 | HP:0045051 | Decreased DLCO | 2 | TERT CL E G H | 7015 | 11730 | OMIM:178500 | Pulmonary fibrosis, idiopathic | | | | 238 | | |
HP:0030878 | HP:0045051 | Decreased DLCO | 2 | TINF2 CL E G H | 26277 | 11824 | OMIM:613990 | Dyskeratosis congenita, autosomal dominant 3 | | | | 60 | | |
HP:0030878 | HP:0045051 | Decreased DLCO | 2 | XYLT1 CL E G H | 64131 | 15516 | OMIM:264800 | PSEUDOXANTHOMA ELASTICUM; PXE | | | | 14 | | |
HP:0030878 | HP:0045051 | Decreased DLCO | 2 | XYLT2 CL E G H | 64132 | 15517 | OMIM:264800 | PSEUDOXANTHOMA ELASTICUM; PXE | | | | 5 | | |